Skip to main content

XBiotech Inc.

XBIT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626878

No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding XBiotech Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of XBIT: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders5553−2
Shares4.48M3.42M−1.06M (−23.7%)
Value$14.5M$10.1M−$4.36M (−30.1%)

New holders (16)

Institutions that held XBiotech Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to XBIT in Q2 2025
InstitutionSharesValue% of portfolio
RBF Capital, LLC200,000$594.0K0.03%
Y-Intercept (Hong Kong) Ltd47,885$142.2K0.00%
Squarepoint Ops LLC39,776$118.1K0.00%
Citadel Advisors LLC32,483$96.5K0.00%
Qube Research & Technologies Ltd32,218$95.7K0.00%
Cubist Systematic Strategies, LLC25,917$77.0K0.00%
Jane Street Group, LLC25,322$75.2K0.00%
XTX Topco Ltd20,408$60.6K0.00%
Jain Global LLC17,629$52.4K0.00%
Point72 Asia (Singapore) Pte. Ltd.13,725$40.8K0.01%
Russell Investments Group, Ltd.1,425$4.23K0.00%
Simplex Trading, LLC864$2.00K0.00%
Raymond James Financial Inc358$1.06K0.00%
Essential Partners LLC33$980.00%
Larson Financial Group LLC21$620.00%
Clearstead Advisors, LLC17$510.00%

Sold out (18)

Institutions that held XBiotech Inc. at the end of Q1 2025 and filed for Q2 2025 without it.